Blueprint Medicines Corp financial data

Symbol
BPMC on Nasdaq
Location
45 Sidney Street, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 1, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 316 % -22.2%
Quick Ratio 5.32 % -51.1%
Debt-to-equity 275 % -21.5%
Return On Equity -48.9 % +59.5%
Return On Assets -13 % +51.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 64.6M shares +3.14%
Common Stock, Shares, Outstanding 64.6M shares +3.15%
Entity Public Float 6.75B USD +77.4%
Common Stock, Value, Issued 65K USD +3.18%
Weighted Average Number of Shares Outstanding, Basic 64.1M shares +4.09%
Weighted Average Number of Shares Outstanding, Diluted 66.5M shares +4.27%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 345M USD -14.5%
Costs and Expenses 736M USD +1.84%
Nonoperating Income (Expense) 20.4M USD -86.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -154M USD +46.5%
Income Tax Expense (Benefit) 1.84M USD +192%
Net Income (Loss) Attributable to Parent -156M USD +46%
Earnings Per Share, Basic -3 USD/shares +47.4%
Earnings Per Share, Diluted -2 USD/shares +49%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 122M USD +7.87%
Accounts Receivable, after Allowance for Credit Loss, Current 78.1M USD +30%
Inventory, Net 13M USD -58.1%
Assets, Current 702M USD -9.6%
Property, Plant and Equipment, Net 36.1M USD -14.1%
Operating Lease, Right-of-Use Asset 61.6M USD -13.5%
Other Assets, Noncurrent 60.5M USD +168%
Assets 1.2B USD +15.1%
Accounts Payable, Current 800K USD -83.8%
Employee-related Liabilities, Current 21.8M USD +8.82%
Accrued Liabilities, Current 122M USD +13.8%
Contract with Customer, Liability, Current 2.28M USD -68.6%
Liabilities, Current 251M USD +21.3%
Contract with Customer, Liability, Noncurrent 8.04M USD +73.4%
Operating Lease, Liability, Noncurrent 65.2M USD -16.9%
Other Liabilities, Noncurrent 6.97M USD +20.9%
Liabilities 853M USD +17.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.24M USD +15.9%
Retained Earnings (Accumulated Deficit) -2.41B USD -6.92%
Stockholders' Equity Attributable to Parent 342M USD +10.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 342M USD +10.1%
Liabilities and Equity 1.2B USD +15.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -54.5M USD +46.3%
Net Cash Provided by (Used in) Financing Activities 9.19M USD -86.3%
Net Cash Provided by (Used in) Investing Activities 65.1M USD -15.6%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 64.6M shares +3.15%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 49.8M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 134M USD +8.17%
Interest Paid, Excluding Capitalized Interest, Operating Activities 21.5M USD +50.3%
Deferred Tax Assets, Valuation Allowance 798M USD +3.01%
Deferred Tax Assets, Gross 819M USD +2.34%
Operating Lease, Liability 82.1M USD -12.3%
Payments to Acquire Property, Plant, and Equipment 1.83M USD +65.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -155M USD +46.1%
Lessee, Operating Lease, Liability, to be Paid 97.8M USD -15.5%
Property, Plant and Equipment, Gross 84.3M USD +4.84%
Operating Lease, Liability, Current 13.7M USD +12.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 19.3M USD +2.89%
Lessee, Operating Lease, Liability, to be Paid, Year One 18.8M USD +3.16%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 15.6M USD -28.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.9M USD +3.25%
Deferred Tax Assets, Operating Loss Carryforwards 244M USD +4.97%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Four 20.5M USD +3.24%
Operating Lease, Payments 4.66M USD +2.57%
Additional Paid in Capital 2.75B USD +7.27%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 4.46M USD -7.3%
Share-based Payment Arrangement, Expense 114M USD +21.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%